Shanghai Juncell Therapeutics

This trial tested a new treatment called GC101 TIL for people with advanced melanoma that has not responded to standard therapies. The treatment uses immune cells taken from the patient's own tumor, grown in a lab, and then given back to the patient. The study enrolled 18 partici…

This early study tested a new therapy called GC203 TIL in 26 people with advanced gynecologic tumors that had stopped responding to standard treatments. Doctors took immune cells from each patient's tumor, genetically modified them to be more powerful, and infused them back. The …

This early-phase trial tested a personalized immunotherapy for people with advanced solid tumors. Doctors removed a sample of each patient's tumor, grew the immune cells (TILs) in a lab, and then infused them back along with another drug. The goal was to see if this approach is s…